The TBI Action Coalition is a new Community Coordination model to accelerate a first generation of diagnostics and treatments for Traumatic Brain Injury (TBI).

The Brain Trauma Blueprint Action Summit was held on October 18-19, 2022 at the Ronald Reagan Building and International Trade Center in Washington DC. This event convened national stakeholder groups across government, academia, foundations, industry, and individuals with lived experience, to plan to execute the TBI Precision Research Roadmap.

Published in the Journal of Neurotrauma, the article focuses on the pressing need for multi-modal biomarkers for traumatic brain injury to guide the development of diagnostics and personalized, targeted therapies.

Published in the Journal of Neurotrauma, the article reviews factors that impact adoption and implementation of best practices for the management of traumatic brain injury (TBI). It also examines enablers of implementation and strategies for mitigating the barriers to optimal uptake.

Cohen Veterans Bioscience, Stanford Brain Performance Center, and the Brain Trauma Foundation announced a collaboration aimed at transforming the treatment recommendations and guidelines for mild traumatic brain injury (TBI) (inclusive of concussion) and advancing the field more broadly toward a precision medicine approach.

The coauthored review discusses the state of preclinical research in traumatic brain injury (TBI), how preclinical models contribute to the success and failure of clinical solutions for TBI, and considerations for their improvement to aid translational science.

Identifying how factors like age, race, and co-existing conditions influence TBI outcomes across populations could inform standardized precision solutions

Announcing the launch of a National TBI Precision Solutions Research Roadmap, the first in a series of publications resulting from the Brain Trauma Blueprint framework program.